Travere Therapeutics to Report Second Quarter 2024 Financial Results
Travere Therapeutics (NASDAQ: TVTX) has announced that it will release its second quarter 2024 financial results on Thursday, August 1, 2024, after the U.S. financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET to discuss the financial results and provide a general business update. Investors can access the webcast and dial-in information on Travere's website at ir.travere.com/events-presentations. An archived version of the call will be available for 30 days on the company's website following the live webcast.
Travere Therapeutics (NASDAQ: TVTX) ha annunciato che rilascerà i suoi risultati finanziari del secondo trimestre 2024 giovedì 1 agosto 2024, dopo la chiusura dei mercati finanziari statunitensi. L'azienda ospiterà una conference call e webcast alle 16:30 ET per discutere i risultati finanziari e fornire un aggiornamento generale sull'attività. Gli investitori possono accedere alle informazioni per la partecipazione al webcast e al dial-in sul sito web di Travere all'indirizzo ir.travere.com/events-presentations. Una versione archiviata della chiamata sarà disponibile per 30 giorni sul sito dell'azienda dopo il webcast dal vivo.
Travere Therapeutics (NASDAQ: TVTX) ha anunciado que publicará sus resultados financieros del segundo trimestre de 2024 el jueves 1 de agosto de 2024, después del cierre de los mercados financieros en EE. UU. La empresa realizará una conferencia telefónica y webcast a las 4:30 p.m. ET para discutir los resultados financieros y proporcionar una actualización general del negocio. Los inversores pueden acceder a la información del webcast y del número para unirse en el sitio web de Travere en ir.travere.com/events-presentations. Una versión archivada de la llamada estará disponible durante 30 días en el sitio de la empresa después del webcast en vivo.
Travere Therapeutics (NASDAQ: TVTX)는 2024년 2분기 재무 결과를 2024년 8월 1일 목요일 미국 금융 시장 마감 후 발표할 예정이라고 발표했습니다. 이 회사는 재무 결과를 논의하고 일반 비즈니스 업데이트를 제공하기 위해 동부 표준시 기준 오후 4시 30분에 컨퍼런스 콜 및 웹캐스트를 개최할 것입니다. 투자자들은 Travere의 웹사이트인 ir.travere.com/events-presentations에서 웹캐스트 및 다이얼인 정보에 접근할 수 있습니다. 실시간 웹캐스트 후에는 회사 웹사이트에 30일 동안 이 통화의 보관 버전이 제공될 것입니다.
Travere Therapeutics (NASDAQ: TVTX) a annoncé qu'il publiera ses résultats financiers du deuxième trimestre 2024 le jeudi 1er août 2024, après la fermeture des marchés financiers américains. L'entreprise organisera une conférence téléphonique et un webinaire à 16h30 ET pour discuter des résultats financiers et fournir une mise à jour générale de l'activité. Les investisseurs peuvent accéder aux informations concernant le webinaire et la composition du numéro sur le site Web de Travere à l'adresse ir.travere.com/events-presentations. Une version archivée de l'appel sera disponible pendant 30 jours sur le site de l'entreprise après le webinaire en direct.
Travere Therapeutics (NASDAQ: TVTX) hat angekündigt, dass es seine Finanzzahlen für das zweite Quartal 2024 am Donnerstag, den 1. August 2024, nach dem Abschluss der US-Finanzmärkte veröffentlichen wird. Das Unternehmen wird um 16:30 Uhr ET eine Telefonkonferenz und ein Webcast durchführen, um die Finanzergebnisse zu besprechen und ein allgemeines Update zum Geschäft zu geben. Investoren können die Informationen zum Webcast und zur Einwahl auf der Website von Travere unter ir.travere.com/events-presentations abrufen. Eine archivierte Version des Anrufs wird nach dem Live-Webcast 30 Tage lang auf der Website des Unternehmens verfügbar sein.
- None.
- None.
SAN DIEGO, July 25, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced it will report second quarter 2024 financial results on Thursday, August 1, 2024, after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET.
The webcast and dial-in information can be accessed on the Investor page of Travere’s website at ir.travere.com/events-presentations. Following the live webcast, an archived version of the call will be available for 30 days on the Company’s website.
About Travere Therapeutics
At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com.
Contact Info
| Media: 888-969-7879 mediarelations@travere.com | Investors: 888-969-7879 IR@travere.com |
FAQ
When will Travere Therapeutics (TVTX) report its Q2 2024 financial results?
What time is Travere Therapeutics' (TVTX) Q2 2024 earnings call scheduled for?
Where can I access Travere Therapeutics' (TVTX) Q2 2024 earnings webcast?
How long will the archived version of Travere Therapeutics' (TVTX) Q2 2024 earnings call be available?
